Stefan Steigmiller

Title: The Innovative Contributions of Stefan Steigmiller

Introduction

Stefan Steigmiller is a notable inventor based in Freiburg, Germany. He has made significant contributions to the pharmaceutical industry through his innovative methods. His work focuses on improving the preparation of pharmaceutical products, which is crucial for enhancing drug efficacy and safety.

Latest Patents

Steigmiller holds a patent for a method of preparing a pharmaceutical product. This method involves several steps, including providing a neat active pharmaceutical ingredient (API) that meets specific parameters determined by a FT4 powder rheometer. The parameters include a specific basic flow energy of at most 60 mJ/g, a stability index of 0.75 to 1.25, and other critical factors that ensure the quality of the pharmaceutical product. The process also includes dispensing the API into a pharmaceutical carrier and encapsulating it to produce the final product.

Career Highlights

Stefan Steigmiller is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to apply his expertise in pharmaceutical development and contribute to the advancement of medical solutions. His innovative approach has positioned him as a valuable asset in the field.

Collaborations

Steigmiller has worked alongside talented colleagues, including Elodia Di Renzo and David Hook. Their collaborative efforts have fostered an environment of innovation and creativity, leading to advancements in pharmaceutical technologies.

Conclusion

Stefan Steigmiller's contributions to the pharmaceutical industry through his patented methods demonstrate his commitment to innovation and excellence. His work not only enhances the preparation of pharmaceutical products but also reflects the importance of collaboration in achieving groundbreaking advancements.